269 related articles for article (PubMed ID: 7570656)
1. The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures.
Yang RS; el-Masri HA; Thomas RS; Constan AA; Tessari JD
Toxicol Lett; 1995 Sep; 79(1-3):193-200. PubMed ID: 7570656
[TBL] [Abstract][Full Text] [Related]
2. The use of physiologically-based pharmacokinetic/pharmacodynamic dosimetry models for chemical mixtures.
Yang RS; el-Masri HA; Thomas RS; Constan AA
Toxicol Lett; 1995 Dec; 82-83():497-504. PubMed ID: 8597101
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment.
el-Masri HA; Thomas RS; Benjamin SA; Yang RS
Toxicology; 1995 Dec; 105(2-3):275-82. PubMed ID: 8571364
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based pharmacokinetic and pharmacodynamic modeling in health risk assessment and characterization of hazardous substances.
Leung HW; Paustenbach DJ
Toxicol Lett; 1995 Sep; 79(1-3):55-65. PubMed ID: 7570674
[TBL] [Abstract][Full Text] [Related]
5. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
Andersen ME
Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
[TBL] [Abstract][Full Text] [Related]
6. The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances.
Clewell HJ
Toxicol Lett; 1995 Sep; 79(1-3):207-17. PubMed ID: 7570658
[TBL] [Abstract][Full Text] [Related]
7. Application of biologically based computer modeling to simple or complex mixtures.
Liao KH; Dobrev ID; Dennison JE; Andersen ME; Reisfeld B; Reardon KF; Campain JA; Wei W; Klein MT; Quann RJ; Yang RS
Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):957-63. PubMed ID: 12634125
[TBL] [Abstract][Full Text] [Related]
8. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
el-Masri HA; Reardon KF; Yang RS
Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
[TBL] [Abstract][Full Text] [Related]
9. Issues in the pharmacokinetics of trichloroethylene and its metabolites.
Chiu WA; Okino MS; Lipscomb JC; Evans MV
Environ Health Perspect; 2006 Sep; 114(9):1450-6. PubMed ID: 16966104
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone.
el-Masri HA; Thomas RS; Sabados GR; Phillips JK; Constan AA; Benjamin SA; Andersen ME; Mehendale HM; Yang RS
Arch Toxicol; 1996; 70(11):704-13. PubMed ID: 8896716
[TBL] [Abstract][Full Text] [Related]
11. Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.
Yang RS; Thomas RS; Gustafson DL; Campain J; Benjamin SA; Verhaar HJ; Mumtaz MM
Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1385-93. PubMed ID: 9860897
[TBL] [Abstract][Full Text] [Related]
12. Summary of panel discussion on the 'advantages/limitations/uncertainties in the use of physiologically based pharmacokinetic and pharmacodynamic models in hazard identification and risk assessment of toxic substances'.
Frederick CB
Toxicol Lett; 1995 Sep; 79(1-3):201-6. PubMed ID: 7570657
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacodynamic modeling of an interaction threshold between trichloroethylene and 1,1-dichloroethylene in Fischer 344 rats.
el-Masri HA; Constan AA; Ramsdell HS; Yang RS
Toxicol Appl Pharmacol; 1996 Nov; 141(1):124-32. PubMed ID: 8917684
[TBL] [Abstract][Full Text] [Related]
14. The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling to understanding the mechanism of action of hazardous substances.
Medinsky MA
Toxicol Lett; 1995 Sep; 79(1-3):185-91. PubMed ID: 7570655
[TBL] [Abstract][Full Text] [Related]
15. Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling.
Dobrev ID; Andersen ME; Yang RS
Arch Toxicol; 2001 May; 75(3):134-44. PubMed ID: 11409535
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic approaches for mixture risk assessments-present capabilities with simple mixtures and future directions.
Andersen ME; Dennison JE
Environ Toxicol Pharmacol; 2004 Mar; 16(1-2):1-11. PubMed ID: 21782689
[TBL] [Abstract][Full Text] [Related]
17. Extrapolating the future: research trends in modeling.
Menzel DB
Toxicol Lett; 1995 Sep; 79(1-3):299-303. PubMed ID: 7570670
[TBL] [Abstract][Full Text] [Related]
18. The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling.
Bruckner JV; Keys DA; Fisher JW
J Toxicol Environ Health A; 2004 Apr 23-May 28; 67(8-10):621-34. PubMed ID: 15192858
[TBL] [Abstract][Full Text] [Related]
19. In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane.
Dobrev ID; Andersen ME; Yang RS
Environ Health Perspect; 2002 Oct; 110(10):1031-9. PubMed ID: 12361929
[TBL] [Abstract][Full Text] [Related]
20. Mixtures and their risk assessment in toxicology.
Mumtaz MM; Hansen H; Pohl HR
Met Ions Life Sci; 2011; 8():61-80. PubMed ID: 21473376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
